Today: 17 June 2026
Grab inches up in early Singapore trade while Nasdaq moves lower; Form 144, Superbank steps ahead
16 June 2026
2 mins read

Grab inches up in early Singapore trade while Nasdaq moves lower; Form 144, Superbank steps ahead

SINGAPORE, June 17, 2026, 05:03 (SGT)

  • Grab finished Tuesday’s U.S. session at $3.49, up 2.5 cents on the day.
  • Officer Philipp Kandal filed a Form 144 on June 15 to propose a sale of 90,000 common shares.
  • Investors look to cash returns, Superbank consolidation, and a shorter U.S. trading week.

Grab Holdings shares edged up slightly in U.S. trading after Tuesday’s close, while most tech names slipped. The stock was last at $3.49, a gain of 2.5 cents from the prior close. Shares changed hands between $3.44 and $3.62, with volume around 65.6 million.

Nasdaq Composite dropped 1.2% Tuesday, hit by declines in major AI-related stocks. The Dow moved the other way, up 0.6% to notch another record close, according to the Associated Press. Grab’s story is simpler: can rising earnings and cash back to shareholders make up for the volatility in growth names?

The newest company move was procedural. A Form 144 filing showed Philipp Kandal, listed as a Grab officer, planned to sell 90,000 common shares worth about $297,000. The notice also showed earlier sales made under a 10b5-1 insider trading plan.

Execution is still the main issue. Grab reported in May that Q1 revenue was up 24% on the year to $955 million. On-Demand gross merchandise value, or the total value of platform transactions before any deductions, also climbed 24% from a year ago to hit $6.1 billion. Adjusted EBITDA, which excludes interest, taxes, depreciation, amortization and certain other items, gained 46% to $154 million.

Chief Executive Anthony Tan said it’s a “strong start to 2026.” Finance chief Peter Oey said the quarter keeps Grab on pace for 2026 revenue between $4.04 billion and $4.10 billion and adjusted EBITDA of $700 million to $720 million. These numbers are now central to the latest back-and-forth over the stock.

Affordability remains central. Oey said to Reuters in February that Grab plans to “continue to make our rides affordable,” adding that rides are one of the fastest-growing methods for gaining new users. So investors keep an eye on incentives, fuel prices and what consumers are spending. Reuters

Financial services gets another layer. Grab said on May 20 that after a Singtel stake transfer, Superbank will become a subsidiary, bumping Grab’s ownership over 50%. The Indonesian bank’s results are set to be folded into Grab’s Financial Services segment starting in May. “This deal reinforces our long-term commitment to improve financial inclusion in Indonesia,” said Alex Hungate, Grab’s president and COO. Grab Holdings Investor Relations

Grab is pushing further into Indonesia, beyond rides and food. GoTo’s Gojek and Grab have led the ride-hailing business there for years, Reuters said. Sea owns Shopee and Monee, its e-commerce and digital finance brands. Each wants to capture daily user spending. Reuters

Cash returns are still part of the story. Grab in March said it would use up to $400 million from its $500 million buyback plan, splitting it between an accelerated share repurchase and a contingent forward purchase. Oey called the price gap a “clear opportunity to enhance shareholder value.” Grab Holdings Investor Relations

The downside is still clear. Slower spending, higher incentives, credit risk at digital banks, and Superbank integration risk all could hit the operating leverage investors want. Regulation could get tougher. U.S. markets lose a day with Nasdaq shut Friday for Juneteenth, so liquidity could drop, especially for smaller growth names. SEC

Next up for Grab is to show it can keep up revenue, loan growth and ongoing buybacks. The stock gets some support from returning cash. Investors want the operating numbers to catch up.

Stock Market Today

  • Coffee Prices Surge to 5-Week Highs on Brazil Rain Delays and Supply Concerns
    June 16, 2026, 6:44 PM EDT. Coffee prices reached 5-week highs on Tuesday, with Arabica up 5.44% and Robusta rising 1.72%, driven by heavy rain forecasts in Brazil risking harvest delays. Brazil, the world's largest coffee producer, faces persistent rainfall across its coffee regions, supported by a forecast for moderate to heavy rain from Vaisala. ICE Arabica inventories fell to a 6.75-month low, reinforcing supply tightness. Meanwhile, concerns mount over a potential El Niño event, projected to be one of the strongest on record, threatening Brazil's 2026/27 coffee crop with delayed rains during critical flowering months. Despite a USDA forecast of a record 2026/27 Brazil coffee crop of 71.9 million bags, supply risks and tighter shipping conditions caused by the Strait of Hormuz closure bolster prices. Vietnam's rising coffee exports create pressure on Robusta prices, but supply challenges persist for global coffee markets.

Latest articles

Aditxt trades near $0.01 with ADTX filings and Nasdaq delisting risk in focus

Aditxt trades near $0.01 with ADTX filings and Nasdaq delisting risk in focus

17 June 2026
Aditxt shares plunged 17% to $0.0109 amid nearly 929 million shares traded, as Nasdaq delisting risk and uncertainty over the $150 million Ignite Proteomics spin-off overshadowed HRT Financial’s purchase of 4.25 million shares at $0.016; the stock’s fate hinges on compliance and the Ignite deal’s completion.
Sadot Group drops 63% as Nasdaq deadline, deal filings shake investors

Sadot Group drops 63% as Nasdaq deadline, deal filings shake investors

17 June 2026
Sadot Group shares plunged 63.1% to $8.67 after a late-session volatility pause as investors weighed a looming June 22 Nasdaq delisting deadline tied to a stockholders’ equity shortfall, a $125.5 million Los Angeles property option paid with 17.71% of its stock, and ongoing liquidity and default risks.
Pfizer trades up with Rigel’s Veppanu deal done

Pfizer trades up with Rigel’s Veppanu deal done

17 June 2026
Pfizer shares edged up 0.15% to $26.04 after Rigel closed a Veppanu licensing deal with Arvinas and Pfizer, triggering a $35 million payment to Pfizer; the deal highlights ongoing investor focus on whether Pfizer’s oncology and obesity pipeline can offset COVID declines and looming patent losses, with analysts split on pipeline potential versus slow growth and patent pressure.
AAL jumps as oil falls and Jefferies lifts target
Previous Story

AAL jumps as oil falls and Jefferies lifts target

Roblox stock jumps as safety rollout and engagement improve
Next Story

Roblox stock jumps as safety rollout and engagement improve

Go toTop